vaccines

The Department of Health has apologised for mistakenly giving pneumococcal vaccines to two children who were supposed to get hepatitis B vaccinations at the Tin Shui Wai Maternal and Child Health Centre. The department said there was no adverse reaction in the affected kids and paediatricians have assessed that the wrong vaccines do not pose

Kennedy’s war on vaccines has started," one researcher said...

Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots. There’s a catch: The mRNA technology faces growing doubts among Republicans, including people around President Donald Trump. Legislation aimed to ban or limit mRNA vaccines was introduced this year by GOP

Quizzes > Weekly News Quiz — You passed medical training, now see if you can pass our weekly quiz by MedPage Today Staff January 11, 2025 The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted daily, but keeping up

This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and read articles like this first,  sign up here . Later today, around 10 minutes after this email lands in your inbox, I’ll be holding my four-year-old daughter tight as she receives her booster dose of

Science & Nature Reconstituting a plant biosynthetic pathway enables a sustainable supply of vaccine adjuvants...Read MoreGaylene Schildgen

If you’ve had your two-shot vaccination against COVID, followed by two boosters and a bivalent booster, each about five or six months apart, Alberta Health Services will not allow you to have another booster. It’s the same elsewhere in Canada. The post Two COVID vaccines and two boosters means no more shots...

The chikungunya candidate VLA1553 is a live-attenuated monovalent vaccine obtained by deleting a part of the chikungunya virus genome. Phase 3 trial data released in December show that 96–99% of adults develop a neutralizing antibody response that persists for up to a year after a single immunizing shot. To facilitate access in low- and middle-income